Xtl Biopharma Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0010854979
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 52.8L 191.02Cr 44Cr |
---|---|---|---|---|---|
Net income 2022 | -10L -36Cr -8.35Cr | Net income 2023 | -10L -36Cr -8.35Cr | EV / Sales 2022 | - |
Net cash position 2022 | 37.21L 134.61Cr 31Cr | Net cash position 2023 | 20.06L 73Cr 17Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.72
x | P/E ratio 2023 |
-2.96
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.3% |
Managers | Title | Age | Since |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/14/30 |
Itay Weinstein
DFI | Director of Finance/CFO | 52 | 01/99/01 |
Doron Turgeman
CHM | Chairman | 56 | 30/14/30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/14/30 |
Director/Board Member | 57 | 29/20/29 | |
Director/Board Member | 53 | 01/17/01 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 4.66TCr | |
+45.38% | 4.17TCr | |
+0.69% | 4.12TCr | |
+30.52% | 3.24TCr | |
+22.30% | 2.82TCr | |
-6.35% | 2.81TCr | |
+49.25% | 1.45TCr | |
+49.18% | 1.37TCr | |
+3.45% | 1.22TCr |